Newsom-Davis J
Neurosciences Group, University of Oxford, John Radcliffe Hospital, UK.
Curr Opin Neurol. 1997 Feb;10(1):18-21. doi: 10.1097/00019052-199702000-00005.
This review primarily concerns two issues. First, in myasthenia gravis, what mechanisms are likely to underlie the low threshold for extraocular muscle involvement in this disease? Second, what is the likely importance of anti-GQ1b ganglioside antibodies in the diagnosis and causation of Miller-Fisher syndrome?
